Lv1
30 积分 2023-09-25 加入
The preclinical discovery and development of orelabrutinib as a novel treatment option for B-cell lymphoid malignancies
17天前
已完结
B Cell Antigen Receptor Signaling: Roles in Cell Development and Disease
18天前
已完结
IL-2/CD25: A Long-Acting Fusion Protein That Promotes Immune Tolerance by Selectively Targeting the IL-2 Receptor on Regulatory T Cells
23天前
已完结
Discovery of Lanraplenib (GS-9876): A Once-Daily Spleen Tyrosine Kinase Inhibitor for Autoimmune Diseases
1个月前
已完结
Safety and efficacy of fostamatinib in rheumatoid arthritis patients with an inadequate response to methotrexate in phase II OSKIRA-ASIA-1 and OSKIRA-ASIA-1X study
1个月前
已完结
Recent Progress of Molecular Design and Activities of Spleen Tyrosine Kinase (SYK) Inhibitors
1个月前
已完结
New insights into pre-BCR and BCR signalling with relevance to B cell malignancies
1个月前
已完结
Rewiring STAT signaling from the cell surface with Trikine immunotherapeutics
1个月前
已完结
Fostamatinib for the treatment of chronic immune thrombocytopenia
1个月前
已完结
The SYK tyrosine kinase: a crucial player in diverse biological functions
1个月前
已完结
皖公网安备34019202002308
